Prescription Drugs: A Reference Handbook
byDavid E. Newton holds a BA in chemistry, an MA in education from the University of Michigan, and an EdD in science education from Harvard University.
20211130
ABC-CLIO
Pages | 360 |
Topics | Prescription Drug Sources;Prescription Drug Nomenclature;Prescription Drug Abuse;Orphan Drugs;Opiates and Opioids;Human Experimentation;Drug Approval Process;Costs of Prescription Drugs;Clinical Trials;Animal Experimentation;Current Events and Issues: Health and Medicine |
-
eBook
9781440877735
MLA
Newton, David. Prescription Drugs: A Reference Handbook. ABC-CLIO, 2021. ABC-CLIO, publisher.abc-clio.com/9781440877735.
Chicago Manual of Style
Newton, David. Prescription Drugs: A Reference Handbook. ABC-CLIO, 2021. http://publisher.abc-clio.com/9781440877735
APA
Newton, D. (2021). Prescription Drugs: A Reference Handbook. Retrieved from http://publisher.abc-clio.com/9781440877735
- Description
-
Prescription drugs are a basic and invaluable part of society today, but there is debate surrounding the methods of testing new drugs, the possible misuse of prescription drugs, and the economics of drug production and use.
This book examines the evolution of prescription drugs in the United States, as well as the formation of the pharmaceutical industry. It begins with a history of prescription drugs, dating back to their origins, then moves through the Industrial Revolution and into the present day. It also delves into the issues and controversies related to prescription drugs, such as drug costs, regulations, prescription drug abuse, insurance complications, and more. Both implemented and proposed solutions are also discussed. One of the most valuable aspects of the book is that it surveys the history of prescription drugs in a manner that helps the reader identify key issues in an easy-to-understand fashion. Finally, the perspectives chapter allows a broad range of voices to be heard, allowing crucial, diverse perspectives to round out the author's expertise.
- Provides readers with an understanding of the various types of drugs and how they differ in their effects and possible applications
- Introduces a detailed review of the steps involved in the preclinical, clinical, and post-clinical stages of testing of a new prescription drug
- Outlines some major issues in the way experimental drugs are tested, such as gender, age, and racial bias
- Reviews the current status of prescription drug abuse in the United States
- Explains issues involved in the pricing of prescription drugs and issues involved in over-pricing
- Table of Contents
-
Table of Contents
Prescription Drugs: A Reference Handbook
Author(s): Newton, David;Contributors: Newton, David;Abstract:Prescription drugs are a basic and invaluable part of society today, but there is debate surrounding the methods of testing new drugs, the possible misuse of prescription drugs, and the economics of drug production and use.
This book examines the evolution of prescription drugs in the United States, as well as the formation of the pharmaceutical industry. It begins with a history of prescription drugs, dating back to their origins, then moves through the Industrial Revolution and into the present day. It also delves into the issues and controversies related to prescription drugs, such as drug costs, regulations, prescription drug abuse, insurance complications, and more. Both implemented and proposed solutions are also discussed. One of the most valuable aspects of the book is that it surveys the history of prescription drugs in a manner that helps the reader identify key issues in an easy-to-understand fashion. Finally, the perspectives chapter allows a broad range of voices to be heard, allowing crucial, diverse perspectives to round out the author's expertise.
- Provides readers with an understanding of the various types of drugs and how they differ in their effects and possible applications
- Introduces a detailed review of the steps involved in the preclinical, clinical, and post-clinical stages of testing of a new prescription drug
- Outlines some major issues in the way experimental drugs are tested, such as gender, age, and racial bias
- Reviews the current status of prescription drug abuse in the United States
- Explains issues involved in the pricing of prescription drugs and issues involved in over-pricing
SortTitle: prescription drugs: a reference handbookAuthor Info:David E. NewtonauthorDavid E. Newton holds a BA in chemistry, an MA in education from the University of Michigan, and an EdD in science education from Harvard University.
eISBN-13: 9781440877735Cover Image URL: ~~FreeAttachments/9781440877735.jpgPrint ISBN-13: 9781440877728Imprint: ABC-CLIOPages: 360Publication Date: 20211130Series: Contemporary World Issues- Cover Cover11
- Half Title i2
- Series ii3
- Dedication iii4
- Title v6
- Copyright vi7
- Contents vii8
- Preface xiii14
- 1 Background and History 320
- 2 Problems, Controversies, and Solutions 5370
- 3 Perspectives 123140
- Introduction 123140
- The Cork Board 123140
- Climate Change and Prescription Drugs: The Impacts of Increased Temperature on Public Health 127144
- Drug Discovery: A Twentieth-Century Story of Scientific Curiosity, Persistence, and Creative Guesswork 130147
- Will Naloxone Become a Real “Superhero”? 134151
- Drugs and the Professional Bodybuilder 139156
- The Significance of Statistics 143160
- Prescription Drug Ads That Target Consumers 149166
- The Human Brain 153170
- The Second-Best Time 157174
- Sick Full Time 160177
- The Drug Supply Chain and the United States 164181
- Can Information Technology Help Curb Prescription Drug Abuse? 168185
- 4 Profiles 175192
- Alliance for Safe Online Pharmacies 175192
- Bayer AG 178195
- Drug Enforcement Administration 180197
- Carl Durham (1892–1974) 183200
- Hubert Humphrey (1911–1978) 185202
- Paul Janssen (1926–2003) 188205
- Kaiser Family Foundation 191208
- William Proctor Jr. (1817–1874) 192209
- Friedrich Sertürner (1783–1841) 194211
- Alexander “Sasha” Shulgin (1925–2014) 196213
- Daniel B. Smith (1792–1883) 198215
- 5 Data and Documents 201218
- Data 201218
- Table 5.1. Urban-Rural Differences in Drug Overdose Death Rates, by Sex, Age, and Type of Drugs Involved, 1999–2017 202219
- Table 5.2. Strategies Used by U.S. Adults to Reduce Cost of Prescription Drugs, 2013–2017 203220
- Table 5.3. Descriptive Statistics on Prescription Drug Prices for Select Countries, 2018 203220
- Table 5.4. Median Total Cost of Top-Selling Brand-Name Drugs, 2012–2017 204221
- Table 5.5. Prescription Drug Use in the Past 30 Days, by Sex, Race and Hispanic Origin, and Age: United States, Selected Years 1988–1994through 2013–2016 206223
- Table 5.6. Trends in Use of One or More Prescription Drugs in the Past 30 Days, by Age,2007–2016 207224
- Table 5.7. Most Commonly Used Prescription Drug Types in the Past 30 Days, by Age Group, 2015–2016 207224
- Documents 208225
- Durham-Humphrey Amendment (1951) 208225
- Controlled Substances Act (1970) 210227
- Orphan Drug Act of 1983 214231
- Drug Price Competition and Patent Term Restoration Act (1984) 215232
- Prescription Drug Marketing Act of 1987 218235
- State Doctor Shopping Laws (1990/2011) 220237
- Prescription Drug User Fee Act (1992) 222239
- Animal Drug Availability Act (1996) 226243
- Ryan Haight Online Pharmacy Consumer Protection Act of 2008 229246
- FDA Bad Ad Program (2010) 231248
- United States ex rel. Michael Mullen v. AmerisourceBergen Corporation, et al. (2018), 234251
- American Patients First (2018) 237254
- Generic Drugs: Questions & Answers (2018) 240257
- Association for Accessible Medicines v. Frosh (2018) 243260
- Medicare Prescription Drug Coverage (2020) 247264
- The American Hospital Association v. Azar (2020) 251268
- 6 Resources 257274
- 7 Chronology 305322
- Glossary 321338
- Index 331348